SOTORASIB | SOTORASIB | ATC L01XX73
ANTINEOPLASTIC TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) INHIBITOR OF THE RAS GTPASE FAMILY COVALENT DRUG | ORAL | Tmax 1 HOUR VD 211 LITER PPB 89 PERCENT Cl 26.2 LITER / HOUR HT 5 HOUR SOLUBILITY 0.03 MILLIGRAM PER MILLILITER | KRAS(G12C) | GTPase KRas UNIPROT P01116 KRAS more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |